The growth of bioreactors in pharmaceutical, technological advancements in bioreactors, and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the prime factors responsible for the growth of the bioreactor market currently.
Biopharmaceuticals are utilized in a range of applications, from being in the production of biopharmaceuticals to applications in tissue engineering, such as cell expansion and generation of 3D tissue constructs. Bioreactors are, thus, used in providing a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells or cellular constructs incorporated into them. Bioreactors have thus been utilized in many different areas of industry and research and for the progression of in vitro models of 2D cultures and suspensions to 3D constructs, mimicking the natural physiological state in situ. They have also proven to be crucial medicines that are used in autoimmune disorders, cancer, asthma, and organ rejection. Thus, the growth of bioreactors in the pharmaceutical sector is the major factor augmenting the growth of the market.
Furthermore, the technological advancements in bioreactors have improved the flexibility, quality, and scalability of operations with low capital and energy requirements. The innovative methods and the analytical tools are thus projected to enhance the process robustness, accelerate scale-up to industrial production, and drive the efficient use of resources. The extensive use of hybrid bioreactor technology in effective waste management has also further accelerated the expansion of the market.
Key Market Trends
Single Use Bioreactors Segment is Expected to Grow Fastest During the Forecast Period
Stainless steel bioreactors from the material type segmentation are expected to hold the largest market share in the coming future. However, the single-use bioreactors are believed to have a faster growth compared to that of glass material bioreactors and stainless steel bioreactors. The single-use bioreactors are expected to witness a CAGR of 7.26% over the forecast period.
In the recent years, the single-use bioreactors have been increasingly adopted in the modern biopharmaceutical processes. This is primarily due to their unique ability to enhance flexibility, reduce investment, and limit operational costs. The recent years have observed companies specializing in the development of single-use bioreactors, using a process that can modify the existing glass bioreactors to a single-use bioreactor in seconds. Distek Inc. also developed a benchtop SUB system for mammalian cell growth and recombinant protein production. The increasing funding for the biotechnology segment is also boosting the segment growth. Therefore, for the ablove reasons this segment is expected to have the fastest growth in the near future.
North America holds the Largest Market share of the Bioreactor Market currently and is believed to the Same Trend Over the Forecast Period
North America currently dominates the market for bioreactors, and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future owing to the rise in collaborations among the industry and academic institutions. The United States holds the majority of the market in the North American region; this is because pharmaceuticals and hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.
The growing demand for biopharmaceutical products in the region and the focus to increase localized production are expected to have a positive impact on the market over the forecast period.
The bioreactor market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with lower prices. Companies, like Sartorius AG, Thermo Fisher Scientific Inc., Pall Corporation (Danaher Corporation), and Eppendorf AG hold the significant market share in the bioreactor market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support